SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Guidance and Visibility -- Ignore unavailable to you. Want to Upgrade?

To: SusieQ1065 who wrote (3405)7/5/2001 9:07:20 AM
From: SusieQ1065  Read Replies (1) | Respond to of 208838
 
09:00 ET ViroLogic (VLGC) 2.75: PhenoSense HIV drug resistance assay demonstrates that HIV patient outcomes can be significantly improved by the presence of enhanced susceptibility to antiviral drugs. PhenoSense HIV is the only commercially available drug resistance test able to detect hypersusceptibility to HIV drugs. The study was published in the journal AIDS.



To: SusieQ1065 who wrote (3405)7/5/2001 9:10:35 AM
From: keithcray  Read Replies (2) | Respond to of 208838
 
SANM trying to move on upgrade.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News